Changes in Myocardial Perfusion During Chronic Multi Site Biventricular Versus Right Ventricular Apex Pacing in Patients With Normal Left Ventricular Function Undergoing His Bundle Ablation for Drug-refractory Atrial Fibrillation
NCT ID: NCT00528307
Last Updated: 2014-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
5 participants
INTERVENTIONAL
2007-10-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
His-bundle Pacing vs. Right Ventricular Apical Pacing in Patients With Reduced Ejection Fraction
NCT04529577
Benefit of Permanent Stimulation of the Left Branch of the His Bundle Versus Right Ventricular Stimulation After Atrioventricular Node Ablation for Rapid Atrial Fibrillation
NCT06061978
Left Bundle Branch Pacing Versus Right Ventricular Pacing in Patients With Atrioventricular Block
NCT05722379
Left Bundle Branch Pacing Versus Conventional Pacing in Atrioventricular Block
NCT05129098
The Relationship Between Left Atrial Pressure and Cardiac Function After Atrioventricular Node Ablation
NCT05449158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
First 3 months of biventricular pacing, second 3 months right ventricular apical pacing
HIS buldle ablation
HIS bundle ablation, followed by implant of a biventricular pacemaker
2
First 3 months of right ventricular apical pacing, second 3 months biventricular pacing
HIS buldle ablation
HIS bundle ablation, followed by implant of a biventricular pacemaker
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HIS buldle ablation
HIS bundle ablation, followed by implant of a biventricular pacemaker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Drug-refractory, persistent or permanent atrial fibrillation
* Referred for His ablation
Exclusion Criteria
* Life expectancy \< 1year from non-cardiac causes
* Previous myocardial infarction
* Previous coronary bypass surgery
* Poor left ventricle function (EF\< 40%) from any cause
* Symptomatic obstructive coronary artery disease
* Poor ultra sound imaging quality.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
R&D Cardiologie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vincent van Dijk
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lucas VA Boersma, MD, PHD
Role: PRINCIPAL_INVESTIGATOR
St. Antonius Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Antonius Hospital
Nieuwegein, Utrecht, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RDC-2006-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.